Showing results (971-980 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|December 22, 2011
Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategyThierry Marysael, Matthias Bauwens, Yicheng Ni, et al.
Investigational New Drugs|December 29, 2011
Bay846, a new irreversible small molecule inhibitor of EGFR and Her2, is highly effective against malignant brain tumor modelsSharon L Longo, David J Padalino, Sandra McGillis, et al.
Investigational New Drugs|March 23, 2011
Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2Alicia A Goyeneche, Erin E Seidel, Carlos M Telleria
Investigational New Drugs|July 26, 2011
A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancerEmma K Beardsley, Sebastien J Hotte, Scott North, et al.
Investigational New Drugs|July 29, 2011
A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastomaWayne L Furman, Lisa M McGregor, M Beth McCarville, et al.
Investigational New Drugs|August 17, 2011
Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancerByung Woog Kang, Jong Gwang Kim, Yee Soo Chae, et al.
Investigational New Drugs|August 10, 2011
Synergistic effects of the combination of β-ionone and sorafenib on metastasis of human hepatoma SK-Hep-1 cellsChin-Shiu Huang, Shih-Chieh Lyu, Miao-Lin Hu
Investigational New Drugs|July 20, 2011
Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian studyGerardo Rosati, Stefano Cordio, Giuseppe Aprile, et al.
Investigational New Drugs|August 3, 2011
Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: a preliminary open-label studyQing Zhang, Hong Chen, Qin Li, et al.
Investigational New Drugs|August 3, 2011
Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignanciesMaarten J Deenen, Heinz-Josef Klümpen, Dick J Richel, et al.
Pageof 372